Guidelines for the Use of Erythropoietic Proteins in Anaemic Patients with Cancer

Anaemia is a frequent finding in cancer patients and should be carefully assessed. Additional causes of anaemia such as iron deficiency, bleeding, nutritional defects or haemolysis should be corrected prior to erythropoietic protein therapy. The following recommendations are related to adult cancer patients with solid tumours or haematological malignancies:
Continue reading

Guidelines for the Clinical Use of Red Cell Transfusions

The red blood cell transfusions should not be dictated by a single hemoglobin “trigger” but instead should be based on the patient’s risks of developing complications of inadequate oxygenation. Red blood cell transfusion is rarely indicated when the hemoglobin concentration is greater than 10 g/dL and is almost always indicated when it is less than 6 g/dL.

Continue reading

Current Indications for Use of the Swan-Ganz Catheter

The Swan-Ganz balloon flotation catheter was introduced  in clinical use by H. J. C. Swan and William Ganz in 1970. Since then, the catheter has been used in many kinds of clinical fields, such as critical care medicine, cardiovascular surgery, anesthesia, and cardiology, because of its useful functions.
Continue reading

Recommendations for the Use of Ambulatory Blood-Pressure Monitoring

In addition to the prediction of cardiovascular risk, ambulatory blood-pressure monitoring, when used in conjunction with clinic blood-pressure assessments, is of potential value in a variety of other clinical conditions. Some of these conditions are:
Continue reading